These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 33345901)

  • 1. Subchronic toxicity evaluation of glucosamine and glucosamine in combination with chondroitin sulfate in obese Zucker rats.
    Leakey JEA; Ali AA; Babb AR; Badgley HL; Davis KJ; Juliar BE; Leakey TI; Lewis SM; Patton RE; Seng JE
    Toxicol Appl Pharmacol; 2021 Feb; 412():115371. PubMed ID: 33345901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral glucosamine increases expression of transforming growth factor β1 (TGFβ1) and connective tissue growth factor (CTGF) mRNA in rat cartilage and kidney: implications for human efficacy and toxicity.
    Ali AA; Lewis SM; Badgley HL; Allaben WT; Leakey JE
    Arch Biochem Biophys; 2011 Jun; 510(1):11-8. PubMed ID: 21466783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term blockade of angiotensin AT1 receptors increases survival of obese Zucker rats.
    Janiak P; Bidouard JP; Cadrouvele C; Poirier B; Gouraud L; Grataloup Y; Pierre F; Bruneval P; O'Connor SE; Herbert JM
    Eur J Pharmacol; 2006 Mar; 534(1-3):271-9. PubMed ID: 16516882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk assessment for glucosamine and chondroitin sulfate.
    Hathcock JN; Shao A
    Regul Toxicol Pharmacol; 2007 Feb; 47(1):78-83. PubMed ID: 16942821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronically increased intrarenal angiotensin II causes nephropathy in an animal model of type 2 diabetes.
    Sharma R; Sharma M; Reddy S; Savin VJ; Nagaria AM; Wiegmann TB
    Front Biosci; 2006 Jan; 11():968-76. PubMed ID: 16146787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of oral glucosamine and chondroitin sulfate alone and in combination on the metabolism of SHR and SD rats.
    Echard BW; Talpur NA; Funk KA; Bagchi D; Preuss HG
    Mol Cell Biochem; 2001 Sep; 225(1-):85-91. PubMed ID: 11716368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early treatment with GLP-1 after severe trauma preserves renal function in obese Zucker rats.
    Xiang L; Thompson MS; Clemmer JS; Mittwede PN; Khan T; Hester RL
    Am J Physiol Regul Integr Comp Physiol; 2019 May; 316(5):R621-R627. PubMed ID: 30811247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary intake of cod protein beneficially affects concentrations of urinary markers of kidney function and results in lower urinary loss of amino acids in obese Zucker fa/fa rats.
    Drotningsvik A; Midttun Ø; McCann A; Ueland PM; Høgøy I; Gudbrandsen OA
    Br J Nutr; 2018 Oct; 120(7):740-750. PubMed ID: 30156176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prostacyclin analog beraprost sodium ameliorates characteristics of metabolic syndrome in obese Zucker (fatty) rats.
    Sato N; Kaneko M; Tamura M; Kurumatani H
    Diabetes; 2010 Apr; 59(4):1092-100. PubMed ID: 20068136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rice endosperm protein slows progression of fatty liver and diabetic nephropathy in Zucker diabetic fatty rats.
    Kubota M; Watanabe R; Yamaguchi M; Hosojima M; Saito A; Fujii M; Fujimura S; Kadowaki M
    Br J Nutr; 2016 Oct; 116(8):1326-1335. PubMed ID: 27724997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary salt restriction improves cardiac and adipose tissue pathology independently of obesity in a rat model of metabolic syndrome.
    Hattori T; Murase T; Takatsu M; Nagasawa K; Matsuura N; Watanabe S; Murohara T; Nagata K
    J Am Heart Assoc; 2014 Dec; 3(6):e001312. PubMed ID: 25468654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety assessment of non-animal chondroitin sulfate sodium: Subchronic study in rats, genotoxicity tests and human bioavailability.
    Miraglia N; Bianchi D; Trentin A; Volpi N; Soni MG
    Food Chem Toxicol; 2016 Jul; 93():89-101. PubMed ID: 27108107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The male obese Wistar diabetic fatty rat is a new model of extreme insulin resistance.
    Greene SF; Johnson PR; Eiffert KC; Greenwoodt MR; Stern JS
    Obes Res; 1994 Sep; 2(5):432-43. PubMed ID: 16358398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Energy restriction reduces the number of advanced aberrant crypt foci and attenuates the expression of colonic transforming growth factor beta and cyclooxygenase isoforms in Zucker obese (fa/fa) rats.
    Raju J; Bird RP
    Cancer Res; 2003 Oct; 63(20):6595-601. PubMed ID: 14583451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune responsiveness in a rat model for type II diabetes (Zucker rat, fa/fa): susceptibility to Candida albicans infection and leucocyte function.
    Plotkin BJ; Paulson D; Chelich A; Jurak D; Cole J; Kasimos J; Burdick JR; Casteel N
    J Med Microbiol; 1996 Apr; 44(4):277-83. PubMed ID: 8606356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nutraceuticals as therapeutic agents in osteoarthritis. The role of glucosamine, chondroitin sulfate, and collagen hydrolysate.
    Deal CL; Moskowitz RW
    Rheum Dis Clin North Am; 1999 May; 25(2):379-95. PubMed ID: 10356424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. YM440, a novel hypoglycemic agent, protects against nephropathy in Zucker fatty rats via plasma triglyceride reduction.
    Nakano R; Kurosaki E; Shimaya A; Kajikawa S; Shibasaki M
    Eur J Pharmacol; 2006 Nov; 549(1-3):185-91. PubMed ID: 16989806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycophenolate mofetil ameliorates nephropathy in the obese Zucker rat.
    Rodríguez-Iturbe B; Quiroz Y; Shahkarami A; Li Z; Vaziri ND
    Kidney Int; 2005 Sep; 68(3):1041-7. PubMed ID: 16105034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-cell mass dynamics in Zucker diabetic fatty rats. Rosiglitazone prevents the rise in net cell death.
    Finegood DT; McArthur MD; Kojwang D; Thomas MJ; Topp BG; Leonard T; Buckingham RE
    Diabetes; 2001 May; 50(5):1021-9. PubMed ID: 11334404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of phytostanol phosphoryl ascorbate (FM-VP4) on insulin resistance, hyperglycemia, plasma lipid levels, and gastrointestinal absorption of exogenous cholesterol in Zucker (fa/fa) fatty and lean rats.
    Wasan KM; Zamfir C; Pritchard PH; Pederson RA
    J Pharm Sci; 2003 Feb; 92(2):281-8. PubMed ID: 12532378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.